KIFAP3 antibody

Cat.#: 107362

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    KIFAP3 antibody
  • Documents
  • Description
    KIFAP3 Mouse Monoclonal antibody. Positive WB detected in human testis tissue. Positive IHC detected in human testis tissue. Observed molecular weight by Western-blot: 91-100kd
  • Tested applications
    ELISA, WB, IHC
  • Species reactivity
    Human,Mouse, Rat; other species not tested.
  • Alternative names
    dJ190I16.1 antibody; FLJ22818 antibody; KAP 3 antibody; KAP3 antibody; KIF3AP antibody; KIFAP3 antibody; kinesin assOCiated protein 3 antibody; SMAP antibody; Smg GDS antibody; Smg GDS assOCiated protein antibody
  • Isotype
    Mouse IgG2a
  • Preparation
    This antibody was obtained by immunization of KIFAP3 recombinant protein (Accession Number: NM_014970). Purification method: Protein A purified.
  • Clonality
    Monoclonal
  • Formulation
    PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: 1:500-1:5000

    IHC: 1:20-1:200

  • Validations

    human testis tissue were subjected to SDS PAGE followed by western blot with Catalog No:107362(KIFAP3 antibody) at dilution of 1:1000

    human testis tissue were subjected to SDS PAGE followed by western blot with Catalog No:107362(KIFAP3 antibody) at dilution of 1:1000

    Immunohistochemistry of paraffin-embedded human testis tissue slide using Catalog No:107362(KIFAP3 Antibody) at dilution of 1:50

    Immunohistochemistry of paraffin-embedded human testis tissue slide using Catalog No:107362(KIFAP3 Antibody) at dilution of 1:50

  • Background
    KIFAP3, also known as KIF3AP or KAP3, is a novel KIF3A/3B-associated protein. It binds to the tail domain of KIF3A/3B and may play a role in regulating the binding of KIF3A/3B to cargoes. Recently it has been reported that mutation within the KIFAP3 gene is associated with decreased KIFAP3 expression and increased survival in sporadic ALS, which makes it a potential target for ALS therapy. KIFAP3 has also been identified as the target of mir-130a.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"